Prices delayed by at least 15 minutes | Print


Humana (HUM)

Common Stock
Sell: $334.22|Buy: $338.44|Change: 0.91 (0.27%)

Open 

$336


Previous close 

$334.68


Trade high 

$338.46


Volume 

1,340,172


Year high 

$530.54


Year low 

$298.61


Dividend yield 

1.05%


Market capitalisation 

$40.44 bn


P/E ratio 

20.66


ISIN 

US4448591028


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Dividends

PreviousLatest
Record date29/03/202428/06/2024
Ex-dividend date27/03/202428/06/2024
Payment date26/04/202426/07/2024
Amount$0.885$0.885

Performance 10/05/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Humana+ 0.27
More...

Company profile

Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.